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Abstract
Necrotizing fasciitis is a rapidly progressive, life-threatening soft tissue bacterial infection. We
present a serious case of a 43-year-old male who suffered from necrotizing fasciitis of the left leg
in whom a delayed diagnosis caused multiorgan dysfunction.
Early recognition of important symptoms is essential in the management and surgical debridement
of necrotizing fasciitis. Treatment should include comprehensive supportive measures (early goal-
directed therapy, adequate ventilation strategy, activated protein C dosage, tight glucose control,
steroids, renal replacement therapy) and early antibiotic therapy based on microbiologic
monitoring. The pathophysiology and etiologic factors of necrotizing fasciitis are discussed.
Introduction
Necrotizing fasciitis (NF) is a rapidly progressive, life-
threatening soft tissue infection. It develops from a bacte-
rial infection, most often with group A Streptococcus
(GAS). However, mixed aerobic and anaerobic Gram pos-
itive (G+) and Gram negative (G-) flora may also be the
infectious agents. Their growth takes place in an environ-
ment of local tissue hypoxia with decreased function of
polymorphonuclear leukocytes, particularly in patients
with the following risk factors: medical compromise (e.g.,
systemic illnesses, immunosuppressive medications),
trauma, recent surgery, recent birth, diabetes mellitus, vas-
cular insufficiency, renal and hepatic failure, cancer, organ
transplants [1]. The key to increasing the chances survival
for a patient with NF is early and proper diagnosis.
Case presentation
A 43-years-old Caucasian male (height 198 cm, weight
115 kg, tobacco smoker – 1 packet of cigarettes/day) was
admitted to the intensive care unit (ICU) of a university
hospital from a municipal hospital because of multiorgan
dysfunction syndrome associated with infection and
necrosis of the skin, subcutaneous tissue, and fascia of the
left lower leg. The signs and symptoms of the disease –
edema and pain affecting the left leg-began 7 days before
admission. The patient's medical history was significant
for hepatitis C (HCV), treated with ribavarin and inter-
feron, and diabetes mellitus treated with insulin. On the
day of admission the HCV-RNA test was negative. A mos-
quito bite was the probable triggering event.
On admission to the ICU the patient was confused, with
a Glasgow Coma Scale (GCS) of 9. He was afebrile, had
tachycardia, with a heart rate of 120 beats per minute,
hypotension, with a blood pressure of 90/50 mmHg, and
relative respiratory insufficiency (oxygen saturation of
88% – 90%). He had moderately-dilated pupils with a
delayed light reflex. We noted crepitus over the bilateral
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lung fields, a tender abdomen with absent bowel sounds,
and oliguria. There were numerous hemorrhagic extrava-
sations on the skin. Examination of the left leg revealed
diffuse edema of the skin, with marked erythema and
necrosis; margins of infection were sharply demarcated,
spreading onto the buttock and perineum on the left side
(Figure 1). Laboratory tests showed a metabolic acidosis,
with the following values: base excess -15 mmol/l, lactate
level 7.3 mmol/l, PaO2 64 mmHg, platelet count 29,000/
mm3, International Normalized Ratio (INR) 2.24, serum
creatinine 691.6 μmol/l, bilirubin 62.6 μmol/l, and C-
reactive Protein (CRP) 224.6 μg/dl.
The Acute Physiology and Chronic Health Evaluation
(APACHE) II score on the day of admission was 31 points
and the Sequential Organ Failure Assessment (SOFA)
score was 18 points. The patient required fluid resuscita-
tion, endotracheal intubation, mechanical ventilation in
BiPAP (bilevel positive airway pressure) mode, continu-
ous intravenous infusion of catecholamines (epinephrine,
norepinephrine) and low doses of steroids to restore
blood pressure. After obtaining cultures from the affected
tissue, blood and bronchoalveolar lavage (BAL) in appro-
priate media, empirical, broad-spectrum antibiotics were
immediately administered (meropenem 3 g/day in a 3-h
infusion, vancomycin 3 g/day in continuous infusion,
metronidazole 1.5/day in 3 divided doses). Because of
progressive organ dysfunction, therapy was started with
activated protein C, in doses of 24 μg/kg/h; continuous
veno-venous hemofiltration (CVVH) was also started.
After several hours, the patient developed atrial fibrilla-
tion with a ventricular rate of 140 beats per minute and
his blood pressure decreased to 80/50 mmHg. Electrical
cardioversion was performed three times, followed by
continuous infusion of cordarone (12 mg/kg/day). Dur-
ing this time, intensive fluid resuscitation was adminis-
tered. During the first day, the patient received 12,800 ml
of fluid (colloids and crystalloids). His unstable condition
did not allow for early surgical management.
The cultures from the affected areas of skin contained
Streptococcus pyogenes and Staphylococcus sciuri. Based
on sensitivity results, vancomycin and metronidazole
were discontinued, and penicillin G was started at a dose
of 60 million units a day (intravenous) in 6 divided doses.
Because the patient's poor condition persisted and the
microbes were sensitive to clindamycin, it was added at
2.7 g/day in 3 divided doses. In spite of the lack of infor-
mation about G-pathogens, meropenem was continued.
The patient also received 40 g of commercially available
gamma-globulin (intravenous), 8 units of packed red
blood cells, 6 units of fresh frozen plasma, and 8 units of
platelets. After several days his condition improved, with
urine output of 100–150 ml/h and resolution of his met-
abolic acidosis. On the sixth day, the patient's hemody-
namic parameters deteriorated again, with tachycardia to
160 beats per minute and a decrease in blood pressure to
85/60 mmHg. CVVH was administered again for detoxifi-
cation. On the seventh day, the necrotic tissue was surgi-
cally excised (Figures 2, 3). We also noted a progressive
decline in the white blood cell count to 2,200/mm3, and
administered granulocyte colony stimulating factor.
Cultures of the BAL showed 104 colony-forming units/ml
of methycillin resistant Staphylococcus aureus (MRSA).
(The patient had been a carrier of methycillin susceptible
Staphylococcus aureus [MSSA] isolated from his nose ves-
tibule on admission.) Because MRSA also was present in
blood cultures and the patient's condition remained poor,
linezolid 1.2 g a day in 2 divided doses was initiated based
on additional results of susceptibility tests. After 10 days
43-year-old male Figure 1
43-year-old male. Preoperative photograph on the day of 
admission. Extensive erythema and necrosis of the left leg.
43-year-old male Figure 2
43-year-old male. Seventh day of treatment. Intraoperative 
photographs: necrotic tissue from the left leg was surgically 
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of intensive treatment, the patient was hemodynamically
stable, and we discontinued mechanical ventilation. 25
days after admission the patient was discharged to the
trauma surgery ward for plastic reconstruction of his
wounds.
Discussion
NF is a relatively rare disease, in which infection and
necrosis are most often located on the lower legs and peri-
neum. In 1883, Fournier reported a case of fulminant gan-
grene of the testes in an otherwise healthy man. In 1952,
Wilson [2] used the name "necrotizing fasciitis" to
describe the same disease, located on a different part of
the body. Mortality in NF ranges from 20 to 30%, but is
considerably higher, approximately 80%, when the dis-
ease is associated with sepsis and renal failure [3,4].
The APACHE II score provides an estimated prediction of
ICU mortality based on a number of laboratory values
and signs, taking both acute and chronic diseases into
account. The APACHE II and the SOFA score reflect the
status of the organ systems and are widely used, mainly as
indices of illness severity and for outcome prediction. In
this patient, the APACHE II score reached a very high
value (31 points) with a predicted mortality of 73%.
Early diagnosis is not always possible, because signs such
as erythema, tenderness, swelling, and fever accompany
other inflammatory states of skin and subcutaneous tissue
(e.g., cellulitis). Wong [5] concludes that in 89 examined
patients with NF, only approximately 15% were diag-
nosed properly. Delay in establishing the correct diagno-
sis may have catastrophic repercussions, such as
dynamically developing organ dysfunction, particularly in
patients, such as this, with risk factors. Cornia et al [6]
emphasized that early diagnosis is extremely important
for the implementation of appropriate empiric antibiotics
and this must be based on a clinician's high index of sus-
picion. Advanced necrosis and organ dysfunction in our
patient indicated that the proper diagnosis was seriously
delayed (symptoms began 7 days before admission).
According to Sendi [7] patients with NF can be classified
into two categories. The first category consists of patients
with antecedent surgery, diabetes mellitus and vascular
diseases in whom the infection is usually polymicrobial.
The second category consists of patients in whom NF is
induced by a single pathogen, usually GAS, and these
patients usually have no underlying diseases. Our patient
had perturbations in the functioning of his immunologi-
cal system. The predisposing factors were insulin-depend-
ent diabetes and hepatitis C, treated with
immunosuppressive drugs. The etiologic agent was GAS
and staphylococcus species. GAS is classified depending
on the presence of superficial proteins – T and M antigens.
In the pathophysiology of NF, antigen M plays an espe-
cially significant role because it is responsible for the inef-
ficiency of phagocytosis, which determines the intensity
of the pathogenic virulence. Protein M diminishes activa-
tion of the alternative pathway in the complement system,
by inhibiting the binding of the C3 component to the
microbe cells and increasing their resistance to phagocyto-
sis. The expansion of NF depends on the action of proteo-
lytic toxins and enzymes, produced by bacteria, that are
responsible for the rapid spread of infection, lead to
necrosis of the tissues. The activation of cascade systems
and endothelial injury disturb tissue perfusion, leading to
death due to full-blown septic shock [8]. Pivotal in the
treatment of NF is surgical excision of necrosis as soon as
possible and widely accepted intensive therapy, which
relies on properly selected antibiotics and supportive
treatment for organ failure. Surgical procedures rely upon
executing multiple, wide incisions, ensuring outflow of
infected secretions and removal of necrotic tissue. In the
patient presented here, radical surgery seemed to be dan-
gerous due to serious shock and disseminated intravascu-
lar coagulation. The patient's body mass in combination
with the necrosis affecting a large proportion of his body
surface meant that a complete excision would carry the
risk of massive bleeding. Moreover, we were forced to
employ CVVH with heparin infusion and activated pro-
tein C. Thus, early surgical necrosis excision seems to be
less dangerous in patients without shock and coagulation
perturbation and after stabilization of vital parameters.
Endorf et al [9] presented 65 cases of NF, in which all sur-
gical procedures occurred over a mean of 5.3 days. In
addition, Miller et al [10] reported that this time varied
from 3 days to over 3 months. In spite of the fact that early
surgical treatment was linked to increased mortality, rapid
surgical intervention is still recommended [9,11].
43-year-old male Figure 3
43-year-old male. Seventh day of treatment. Intraoperative 
photographs: necrotic tissue from the left leg was surgically 
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The influence of streptococcal toxins and the subsequent
physiological reactions suggest that penicillin G and clin-
damycin should be administered empirically. Because of
our patient's prior stay in another hospital, we empirically
initiated carbapenem and vancomycin, to cover nosoco-
mial pathogens. Penicillin and clindamycin were admin-
istrated on the third and fourth days of treatment,
respectively, after obtaining microbiological susceptibility
tests. However, an increasing number of published reports
have documented the inefficiency of penicillin in treating
serious GAS infections [8]. The superior effects of clin-
damycin result from its inhibition of toxin and protein M
synthesis, a potency that is independent of the size of the
inoculum or GAS growth phase, and its longer lasting
postantibiotic effect. There are reports about clindamy-
cin's ability to modify the function of the immune system
in GAS infection [8]. Thus, clindamycin remains a relia-
ble, well-established and effective antibiotic in treating
NF.
In this case, the patient presented with signs and symp-
toms of severe sepsis, for which intensive supportive care
measures are the standard of care. These measures include
the 6-hour resuscitation bundle, which consists of lactate
level monitoring, early cultures and antibiotics, and early
goal-directed therapy (intensive fluid resuscitation and
administration of catecholamines). The standard inten-
sive measures also include a 24-hour management bundle
with a physiological approach to ventilation, administra-
tion of activated protein C (which has a multifaceted
mechanism of action), tight glucose control, low-dose
steroids and renal replacement therapy [12]. Alternative
measures, such as hyperbaric oxygen, immunoglobulin or
granulocyte colony-stimulating factor in granulocyto-
penic patients, may also be effective, but have not yet been
tested in controlled studies [8].
Treatment of NF is exceedingly expensive. A study per-
formed in the USA in 2001 showed that the entire cost of
treating one patient amounted to approximately 150,000
US dollars [11].
Conclusion
Although NF is a rare disease, physicians must be well
trained in its diagnosis and treatment, to facilitate prompt
interdisciplinary management. Clinicians assessing
patients with rapidly progressive skin infections should be
aware of the symptoms and have a high index of suspi-
cion.
Patients with NF should be treated in ICUs that offer a
wide range of supportive care for organ dysfunction,
microbiological monitoring and surgical procedures. NF
is one of the greatest challenges from both a therapeutic
and financial perspective.
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